{"product_id":"point-of-care-poc-molecular-diagnostics","title":"Point of Care (POC) Molecular Diagnostics","description":"\u003cp\u003ePoint of Care (POC) Molecular Diagnostics\u003cbr\u003e\nGlobal Point of Care (POC) Molecular Diagnostics Market to Reach $8.8 Billion  by 2030\u003cbr\u003e\nThe global market for Point of Care (POC) Molecular Diagnostics estimated at US$3.2 Billion in the year 2022, is projected to reach a revised size of US$8.8 Billion by 2030, growing at a CAGR of 13.4% over the period 2022-2030. PCR-based, one of the segments analyzed in the report, is projected to record 14.4% CAGR and reach US$5.7 Billion by the end of the analysis period. Growth in the Genetic Sequencing-Based segment is estimated at 10.7% CAGR for the next 8-year period.\u003c\/p\u003e\n\n\u003cp\u003eThe U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 16.3% CAGR\u003cbr\u003e\nThe Point of Care (POC) Molecular Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 16.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 12.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.Select Competitors (Total 64 Featured) - Bayer AGDanaher CorporationDiaSorin SpABiocartis NVMaxim Biomedical, Inc.AccuBioTech Co., Ltd.Abacus Diagnostica Oygenedrive plcMolbio Diagnostics Pvt. Ltd.Mesa Biotech, Inc.Binx HealthCredo Diagnostics Biomedical Pte. LtdGenestat Molecular Diagnostics, LLCAlveo TechnologiesADOR DiagnosticsPlease note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.\u003c\/p\u003e \n\n\u003cp\u003eThe latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.\u003c\/p\u003e \n\n\u003cp\u003ePrior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"September, 2023 \/ 597 Pages \/ MCW16237727","offer_id":47652725457202,"sku":null,"price":6720.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/point-of-care-poc-molecular-diagnostics","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}